CDC Updates Assessment on Long COVID Burden and Recovery Trajectories
The Centers for Disease Control and Prevention released updated national estimates showing that 6.9% of U.S. adults reported current long COVID symptoms as of September 2023. Most of those individuals, 82.5%, had lived
The Centers for Disease Control and Prevention released updated national estimates showing that 6.9% of U.S. adults reported current long COVID symptoms as of September 2023. Most of those individuals, 82.5%, had lived with symptoms for 12 months or longer. The data draw from large population surveys and refine earlier pictures of prevalence, symptom clusters, and daily impact.
Prevalence and Trends
Recent CDC analysis placed current long COVID prevalence at 6.9% among adults. A separate review of trends from 2022 into 2023 noted a modest decline, which may tie to higher vaccination coverage and prior infection rates. These figures rely on self-reported data collected through representative sampling.
Common Symptoms
Fatigue affected 75.7% of adults with long COVID, brain fog appeared in 65.5%, and shortness of breath occurred in 46.4%. Symptoms often clustered together rather than appearing in isolation. The pattern held across multiple survey waves.
Demographic Patterns and Daily Effects
Women, adults aged 35 to 49, and people with preexisting conditions showed higher odds of reporting ongoing symptoms. Among those affected, 26.4% described significant limits on daily activities or work. Earlier 2022 data aligned with these subgroup differences.
What this means
The estimates indicate that long COVID remains present in a measurable share of the adult population and frequently extends well past one year. Symptom profiles stay diverse, and functional effects touch work and routine tasks for more than one in four people reporting the condition. Trends point to a gradual drop in prevalence over the past two years.
Key takeaways
- CDC survey data from September 2023 put current long COVID prevalence at 6.9% of U.S. adults, with 82.5% of cases lasting 12 months or more [1].
- Fatigue, brain fog, and shortness of breath ranked as the three most reported symptoms [1].
- Women, adults 35 to 49, and those with prior health conditions carried elevated reporting rates [2].
- Over one quarter of symptomatic adults noted major limits on daily activities [2].
- Prevalence showed a gradual decline from 2022 through mid-2023 [3].
Limitations
Survey estimates rest on self-reported symptoms and can carry recall or reporting bias. Underdiagnosis or symptom misclassification remains possible. Long-term clinical follow-up data stay limited, and coverage of children plus certain hard-to-reach groups is incomplete.
Last updated: September 2, 2026
- Symptoms and Recovery Among Adults with Post–COVID-19 Condition — United States, September 2023. https://www.cdc.gov/mmwr/volumes/72/wr/mm7241a1.htm
- Long COVID in Adults—United States, 2022. https://www.cdc.gov/mmwr/volumes/71/wr/mm7123e1.htm
- Persistent Symptoms in Adults Aged ≥18 Years After SARS-CoV-2 Infection — United States, January 2022–June 2023. https://www.cdc.gov/mmwr/volumes/72/wr/mm7239a1.htm